Cancer vaccines as a therapeutic modality: The long trek

Cancer Immunology, Immunotherapy : CII
A G Dalgleish, M A Whelan

Abstract

The development of cancer vaccines has been one of the several false dawns in which initial promising Phase I and Phase II clinical data have not been followed up with conclusive Phase III trials. In this review, we describe some of the successes and failures, and review the most likely reasons for Phase III failure, such as protocol changes, which are common between Phase II and III, and poorly defined patient groups. Nevertheless, significant survival results have been reported with autologous vaccines for colorectal, renal and, more recently, prostate cancer. In addition, it is becoming evident that immunotherapy is potentially synergistic with other treatment modalities, such as chemotherapy, which can reduce T-regulatory activity that inhibits the immune response to cancer vaccines. This potential for synergy should allow cancer vaccines to become part of the standard treatment regimen for many common tumours.

References

Jan 1, 1973·Advances in Cancer Research·R W Baldwin
May 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P O LivingstonG Ritter
Mar 20, 2002·Clinical Oncology : a Journal of the Royal College of Radiologists·L AssersohnI E Smith
Apr 16, 2002·Science·Ruslan Medzhitov, Charles A Janeway
Oct 31, 2002·Nature Immunology·Gavin P DunnRobert D Schreiber
Feb 25, 2003·Expert Review of Anticancer Therapy·Sara Lewis, Usha Menon
Jul 10, 2003·Drugs in R&D·UNKNOWN Adis International Ltd
Jul 10, 2003·Critical Reviews in Oncology/hematology·Brian I Rini, Eric J Small
Jun 1, 1964·Journal of the National Cancer Institute·A GLOBERSON, M FELDMAN
Mar 6, 2004·Seminars in Cancer Biology·Eddy C Hsueh, Donald L Morton
May 21, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M E R O'BrienUNKNOWN SR-ON-12 Study Group
Jun 3, 2004·The Lancet Oncology·Bryan T HennessyPeter A Daly
Jul 6, 2004·Immunological Reviews·Eli Gilboa, Johannes Vieweg
Jul 15, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ian D DavisJonathan S Cebon
Sep 15, 2004·Proceedings of the National Academy of Sciences of the United States of America·Yoshihiro OkaHaruo Sugiyama
Nov 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig L SlingluffPriscilla Merrill
Jan 11, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·C L Harper-WynneM E R O'Brien
Feb 3, 2005·International Journal of Cardiology·Wolfgang Koenig
Feb 8, 2005·The Journal of Clinical Investigation·Daniel E SpeiserPedro Romero
Mar 12, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Alex K Pavlou, Mark J Belsey
Apr 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael A MorseH Kim Lyerly
Jun 17, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Agnieska MichaelHardev Pandha
Jun 21, 2005·Nature Reviews. Drug Discovery·Richard M Goldberg
Jun 29, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David P CarboneJay A Berzofsky
Aug 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter AttiaSteven A Rosenberg

❮ Previous
Next ❯

Citations

Jul 20, 2007·Cancer Immunology, Immunotherapy : CII·Robert BrodzikHilary Koprowski
Apr 17, 2008·Cancer Immunology, Immunotherapy : CII·Lynn WenandyMads Hald Andersen
Oct 2, 2008·Cancer Immunology, Immunotherapy : CII·Rikke Baek SørensenMads Hald Andersen
Feb 9, 2008·Nature Reviews. Drug Discovery·Kresten SkakPallavur V Sivakumar
Feb 20, 2008·Prostate Cancer and Prostatic Diseases·D KaranD Lubaroff
Aug 24, 2006·Expert Review of Anticancer Therapy·Mark BowerJustin Stebbing
Dec 5, 2008·Expert Review of Vaccines·Lina ZhaoDaiming Fan
Nov 26, 2015·International Journal of Pharmaceutics·Zahra KakhiBéatrice Heurtault
Sep 11, 2007·Blood Cells, Molecules & Diseases·Stanimir Vuk-Pavlovic
Jun 15, 2007·International Journal of Cancer. Journal International Du Cancer·Dev KaranDavid M Lubaroff
Oct 7, 2006·Biotechnology Progress·K ListnerM Chartrain
May 30, 2012·Nature Reviews. Urology·Dev KaranJ Brantley Thrasher
Jan 10, 2019·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Toan PhamRobert G Ramsay
Oct 9, 2013·Expert Review of Vaccines·Adrian BotKent A Smith
Jul 25, 2018·Annals of Surgical Oncology·Toan PhamRobert Ramsay
Oct 7, 2015·Frontiers in Genetics·Nana H OvergaardGregers Jungersen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
J CopierL Håkansson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
James E Talmadge
© 2021 Meta ULC. All rights reserved